HYZAAR

Product NDC: 0006-0717
11-digit product format: 000060717
Labeler code: 0006
Product ID: 0006-0717_3360bde2-aee8-4fc5-b7e0-2cd410edb079
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: losartan potassium and hydrochlorothiazide
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Merck Sharp & Dohme Corp.
Application: NDA020387
Marketing category: NDA
Marketing start: 1995-04-28
Marketing end: 0000-00-00
Substance: LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE
Active strength: 50 mg/1; mg/1
Pharmacologic classes: Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	0006-0717		D	Discontinued by firm	2026-08-03
excluded package	package	0006-0717	0006-0717-31	D	Discontinued by firm	2026-08-03
excluded package	package	0006-0717	0006-0717-54	D	Discontinued by firm	2026-08-03
excluded package	package	0006-0717	0006-0717-82	D	Discontinued by firm	2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 48 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0006-0717-31	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0006-0717-54	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0006-0717-82	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0006-0717-31	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0006-0717-54	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0006-0717-82	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0006-0717-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0006-0717-54	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0006-0717-82	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0006-0717-31	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0006-0717-54	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0006-0717-82	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0006-0717-31	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0006-0717-54	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0006-0717-82	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0006-0717-31	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0006-0717-54	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0006-0717-82	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0006-0717-31	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0006-0717-54	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0006-0717-82	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0006-0717-31	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0006-0717-54	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0006-0717-82	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0006-0717-31	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0006-0717-54	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0006-0717-82	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0006-0717-31	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0006-0717-54	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0006-0717-82	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0006-0717-31	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0006-0717-54	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0006-0717-82	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0006-0717-31	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0006-0717-54	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0006-0717-82	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N020387-001	HYZAAR	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5MG;50MG	TABLET / ORAL	AB	RLD	1995-04-28
N020387-002	HYZAAR	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25MG;100MG	TABLET / ORAL	AB	RLD	1998-11-10
N020387-003	HYZAAR	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5MG;100MG	TABLET / ORAL	AB	RLD	2005-10-20

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
N020387-001	AB
N020387-002	AB
N020387-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N020387-001	HYZAAR	12.5MG;50MG	TABLET / ORAL	AB	RLD	1995-04-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020387-002	HYZAAR	25MG;100MG	TABLET / ORAL	AB	RLD	1998-11-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020387-003	HYZAAR	12.5MG;100MG	TABLET / ORAL	AB	RLD	2005-10-20	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020387-001	HYZAAR	12.5MG;50MG	TABLET / ORAL	AB	RLD	1995-04-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020387-002	HYZAAR	25MG;100MG	TABLET / ORAL	AB	RLD	1998-11-10	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020387-003	HYZAAR	12.5MG;100MG	TABLET / ORAL	AB	RLD	2005-10-20	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020387-001	HYZAAR	12.5MG;50MG	TABLET / ORAL	AB	RLD	1995-04-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020387-002	HYZAAR	25MG;100MG	TABLET / ORAL	AB	RLD	1998-11-10	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020387-003	HYZAAR	12.5MG;100MG	TABLET / ORAL	AB	RLD	2005-10-20	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020387-001	HYZAAR	12.5MG;50MG	TABLET / ORAL	AB	RLD	1995-04-28	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020387-002	HYZAAR	25MG;100MG	TABLET / ORAL	AB	RLD	1998-11-10	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020387-003	HYZAAR	12.5MG;100MG	TABLET / ORAL	AB	RLD	2005-10-20	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020387-001	HYZAAR	12.5MG;50MG	TABLET / ORAL	AB	RLD	1995-04-28	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020387-002	HYZAAR	25MG;100MG	TABLET / ORAL	AB	RLD	1998-11-10	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020387-003	HYZAAR	12.5MG;100MG	TABLET / ORAL	AB	RLD	2005-10-20	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020387-001	HYZAAR	12.5MG;50MG	TABLET / ORAL	AB	RLD	1995-04-28	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020387-002	HYZAAR	25MG;100MG	TABLET / ORAL	AB	RLD	1998-11-10	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020387-003	HYZAAR	12.5MG;100MG	TABLET / ORAL	AB	RLD	2005-10-20	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020387-001	HYZAAR	12.5MG;50MG	TABLET / ORAL	AB	RLD	1995-04-28	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020387-002	HYZAAR	25MG;100MG	TABLET / ORAL	AB	RLD	1998-11-10	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020387-003	HYZAAR	12.5MG;100MG	TABLET / ORAL	AB	RLD	2005-10-20	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020387-001	HYZAAR	12.5MG;50MG	TABLET / ORAL	AB	RLD	1995-04-28	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020387-002	HYZAAR	25MG;100MG	TABLET / ORAL	AB	RLD	1998-11-10	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020387-003	HYZAAR	12.5MG;100MG	TABLET / ORAL	AB	RLD	2005-10-20	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020387-001	HYZAAR	12.5MG;50MG	TABLET / ORAL	AB	RLD	1995-04-28	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020387-002	HYZAAR	25MG;100MG	TABLET / ORAL	AB	RLD	1998-11-10	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020387-003	HYZAAR	12.5MG;100MG	TABLET / ORAL	AB	RLD	2005-10-20	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N020387-001	HYZAAR	12.5MG;50MG	TABLET / ORAL	AB	RLD	1995-04-28	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N020387-002	HYZAAR	25MG;100MG	TABLET / ORAL	AB	RLD	1998-11-10	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N020387-003	HYZAAR	12.5MG;100MG	TABLET / ORAL	AB	RLD	2005-10-20	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020387-001	HYZAAR	12.5MG;50MG	TABLET / ORAL	AB	RLD	1995-04-28	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020387-002	HYZAAR	25MG;100MG	TABLET / ORAL	AB	RLD	1998-11-10	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020387-003	HYZAAR	12.5MG;100MG	TABLET / ORAL	AB	RLD	2005-10-20	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N020387-001	HYZAAR	12.5MG;50MG	TABLET / ORAL	AB	RLD	1995-04-28	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N020387-002	HYZAAR	25MG;100MG	TABLET / ORAL	AB	RLD	1998-11-10	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N020387-003	HYZAAR	12.5MG;100MG	TABLET / ORAL	AB	RLD	2005-10-20	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N020387-001	HYZAAR	12.5MG;50MG	TABLET / ORAL	AB	RLD	1995-04-28	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N020387-002	HYZAAR	25MG;100MG	TABLET / ORAL	AB	RLD	1998-11-10	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N020387-003	HYZAAR	12.5MG;100MG	TABLET / ORAL	AB	RLD	2005-10-20	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N020387-001	HYZAAR	12.5MG;50MG	TABLET / ORAL	AB	RLD	1995-04-28	`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 107 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N020387-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020387-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020387-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020387-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020387-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020387-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020387-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020387-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020387-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020387-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020387-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020387-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020387-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020387-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020387-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020387-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020387-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020387-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020387-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020387-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020387-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020387-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020387-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020387-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020387-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020387-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020387-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N020387-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N020387-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N020387-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020387-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020387-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020387-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N020387-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N020387-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N020387-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N020387-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N020387-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N020387-003	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N020387-001	AB	1	`8072bd15b7f6…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
c19ec24d-2c40-4b8d-7c20-500ffa3660a1	Product name	3	20260303
0d341e63-aee5-498b-bf9a-b53a43963acf	Product name	1	20260105
1199f4b7-b537-466c-9a1c-cb09131e9f8b	Product name	1	20251117
e1a63b6e-1877-c2c1-01a3-03ea2817aa6f	Product name	3	20251027
b15e9aa6-d523-ca97-480e-570e0543a342	Product name	4	20251024
96816964-c075-ffa7-b7b8-d8570411a3b9	Product name	7	20250305
de29c5c0-90ba-29da-d7ab-0500274708be	Product name	6	20241009
162cbc9d-ecc3-72ba-af9f-c76e2756ef54	Product name	3	20221207
9b303cd4-3186-2454-5706-3137e8b2dfd2	Product name	4	20221110
47fc2fe9-7afb-4be9-989d-787aaa6ad0ea	Product name	1	20200505
a8e65197-7914-7acf-c7ec-914d53819b34	Product name	3	20190624
8b67f333-47d1-8464-7ce4-406d3dbb295f	Product name	7	20190618
89a57420-ab44-5323-14f9-595159145f9b	Product name	2	20190612
c27b049d-3258-48cf-ebe5-08c236ae78e2	Product name	3	20190610
00fc2cf9-672f-3e0b-6afa-43cbc864d058	Product name	4	20180613
15b375b1-89c7-9594-80df-5a8c8864aee0	Product name	3	20180108
a7349398-661d-d9fc-46df-7e128bbd61d9	Product name	5	20171113
1bdb87cf-9b1f-6a51-5eb7-d182aaffaa3d	Product name	2	20170719
e0eeb018-194e-4b70-a57d-bac47a97b8ea	Product name	1	20160825
55bffd21-17e1-ff02-2e8f-1f9a532b9502	Product name	2	20150320
ea069444-e874-4c28-833f-d2f52734ef4d	Product name	1	20150206
041df61b-f8b6-48a6-7b67-411e1412678b	Product name	1	20140508
0ad8bdca-888e-00da-648b-6a4de854a167	Product name	1	20140508
433a3439-b8f3-d13a-d2c8-9b221d628d60	Product name	1	20140508
59212689-39e5-a976-6d21-882d76d8079a	Product name	1	20140508
7613b1a5-acb6-4e5e-6048-c44deeeb1212	Product name	1	20140508
78637fb0-95c8-441f-e4b4-db1274b6f956	Product name	1	20140508
df89bd47-2db4-d593-ab37-d11953fd5536	Product name	1	20140508
f151007d-265d-9fbe-857d-1d44f1cb76ba	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
0006-0717-31	2021-09-15	These highlights do not include all the information needed to use HYZAAR safely and effectively. See full prescribing information for HYZAAR. HYZAAR ® (losartan potassium and hydrochlorothiazide) tablets, for oral use Initial U.S. Approval: 1995
0006-0717-54	2021-09-15	These highlights do not include all the information needed to use HYZAAR safely and effectively. See full prescribing information for HYZAAR. HYZAAR ® (losartan potassium and hydrochlorothiazide) tablets, for oral use Initial U.S. Approval: 1995
0006-0717-82	2021-09-15	These highlights do not include all the information needed to use HYZAAR safely and effectively. See full prescribing information for HYZAAR. HYZAAR ® (losartan potassium and hydrochlorothiazide) tablets, for oral use Initial U.S. Approval: 1995
0006-0717-31	2021-07-23	These highlights do not include all the information needed to use HYZAAR safely and effectively. See full prescribing information for HYZAAR. HYZAAR ® (losartan potassium and hydrochlorothiazide) tablets, for oral use Initial U.S. Approval: 1995
0006-0717-54	2021-07-23	These highlights do not include all the information needed to use HYZAAR safely and effectively. See full prescribing information for HYZAAR. HYZAAR ® (losartan potassium and hydrochlorothiazide) tablets, for oral use Initial U.S. Approval: 1995
0006-0717-82	2021-07-23	These highlights do not include all the information needed to use HYZAAR safely and effectively. See full prescribing information for HYZAAR. HYZAAR ® (losartan potassium and hydrochlorothiazide) tablets, for oral use Initial U.S. Approval: 1995

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0006-0717-28	EA - Each	0006-0717	5020394b-b52d-409f-9177-3c329c807077	1	2013-02-11
0006-0717-31	EA - Each	0006-0717	7fb35d44-08cb-4df3-bbcd-6f54c8ef3d55	1	2012-07-24
0006-0717-54	EA - Each	0006-0717	0f799034-057d-49d5-af2f-320acacfd46e	1	2012-07-24
0006-0717-82	EA - Each	0006-0717	1c32fcad-c818-4758-9168-fac75a76e6ab	1	2012-07-24
0006-0717-86	EA - Each	0006-0717	7d166525-fff6-4929-bcd9-09e72888b533	1	2013-02-11

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
HYDROCHLOROTHIAZIDE	ACTIVE INGREDIENT	0J48LPH2TH	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [BRYANT RANCH PREPACK]	1001
LOSARTAN POTASSIUM	ACTIVE INGREDIENT	3ST302B24A	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [BRYANT RANCH PREPACK]	1001
HYDROCHLOROTHIAZIDE	ACTIVE MOIETY	0J48LPH2TH	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [BRYANT RANCH PREPACK]	1001
LOSARTAN	ACTIVE MOIETY	JMS50MPO89	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [BRYANT RANCH PREPACK]	1001
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [BRYANT RANCH PREPACK]	1001
CARNAUBA WAX	INACTIVE INGREDIENT	R12CBM0EIZ	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [BRYANT RANCH PREPACK]	1001
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [BRYANT RANCH PREPACK]	1001
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [BRYANT RANCH PREPACK]	1001
HYDROXYPROPYL CELLULOSE	INACTIVE INGREDIENT	RFW2ET671P	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [BRYANT RANCH PREPACK]	1001
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [BRYANT RANCH PREPACK]	1001
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [BRYANT RANCH PREPACK]	1001
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [BRYANT RANCH PREPACK]	1001
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [BRYANT RANCH PREPACK]	1001
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [BRYANT RANCH PREPACK]	1001
hydrochlorothiazide	ACTIVE INGREDIENT	0J48LPH2TH	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [MERCK SHARP & DOHME CORP.]	24
losartan potassium	ACTIVE INGREDIENT	3ST302B24A	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [MERCK SHARP & DOHME CORP.]	24
hydrochlorothiazide	ACTIVE MOIETY	0J48LPH2TH	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [MERCK SHARP & DOHME CORP.]	24
losartan	ACTIVE MOIETY	JMS50MPO89	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [MERCK SHARP & DOHME CORP.]	24
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [MERCK SHARP & DOHME CORP.]	24
CARNAUBA WAX	INACTIVE INGREDIENT	R12CBM0EIZ	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [MERCK SHARP & DOHME CORP.]	24
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [MERCK SHARP & DOHME CORP.]	24
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [MERCK SHARP & DOHME CORP.]	24
hydroxypropyl cellulose (type H)	INACTIVE INGREDIENT	RFW2ET671P	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [MERCK SHARP & DOHME CORP.]	24
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [MERCK SHARP & DOHME CORP.]	24
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [MERCK SHARP & DOHME CORP.]	24
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [MERCK SHARP & DOHME CORP.]	24
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [MERCK SHARP & DOHME CORP.]	24
titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [MERCK SHARP & DOHME CORP.]	24
hydrochlorothiazide	ACTIVE INGREDIENT	0J48LPH2TH	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	3
losartan potassium	ACTIVE INGREDIENT	3ST302B24A	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	3
hydrochlorothiazide	ACTIVE MOIETY	0J48LPH2TH	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	3
losartan	ACTIVE MOIETY	JMS50MPO89	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	3
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	3
CARNAUBA WAX	INACTIVE INGREDIENT	R12CBM0EIZ	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	3
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	3
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	3
hydroxypropyl cellulose	INACTIVE INGREDIENT	RFW2ET671P	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	3
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	3
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	3
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	3
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	3
titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	3
hydrochlorothiazide	ACTIVE INGREDIENT	0J48LPH2TH	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	1
losartan potassium	ACTIVE INGREDIENT	3ST302B24A	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	1
hydrochlorothiazide	ACTIVE MOIETY	0J48LPH2TH	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	1
losartan	ACTIVE MOIETY	JMS50MPO89	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	1
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	1
CARNAUBA WAX	INACTIVE INGREDIENT	R12CBM0EIZ	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	1
hydroxypropyl cellulose (type H)	INACTIVE INGREDIENT	RFW2ET671P	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	1
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	1
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	1
titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
HYZAAR	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE	Organon LLC	4116ccde-2e23-45f4-b12f-6337df877744	2025-11-26	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 020387 application number: NDA020387

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
3ST302B24A	LOSARTAN POTASSIUM	124750-99-8	LOSARTAN POTASSIUM
0J48LPH2TH	HYDROCHLOROTHIAZIDE	58-93-5	HYDROCHLOROTHIAZIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
979466	Hyzaar 100 MG / 12.5 MG Oral Tablet	PSN	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979473	Hyzaar 100 MG / 25 MG Oral Tablet	PSN	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979470	Hyzaar 50 MG / 12.5 MG Oral Tablet	PSN	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979464	losartan potassium 100 MG / hydroCHLOROthiazide 12.5 MG Oral Tablet	PSN	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979471	losartan potassium 100 MG / hydroCHLOROthiazide 25 MG Oral Tablet	PSN	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979468	losartan potassium 50 MG / hydroCHLOROthiazide 12.5 MG Oral Tablet	PSN	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979466	hydrochlorothiazide 12.5 MG / losartan potassium 100 MG Oral Tablet [Hyzaar]	SBD	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979470	hydrochlorothiazide 12.5 MG / losartan potassium 50 MG Oral Tablet [Hyzaar]	SBD	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979473	hydrochlorothiazide 25 MG / losartan potassium 100 MG Oral Tablet [Hyzaar]	SBD	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979464	hydrochlorothiazide 12.5 MG / losartan potassium 100 MG Oral Tablet	SCD	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979468	hydrochlorothiazide 12.5 MG / losartan potassium 50 MG Oral Tablet	SCD	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979471	hydrochlorothiazide 25 MG / losartan potassium 100 MG Oral Tablet	SCD	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979464	HCTZ 12.5 MG / Losartan K+ 100 MG Oral Tablet	SY	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979466	HCTZ 12.5 MG / Losartan K+ 100 MG Oral Tablet [Hyzaar]	SY	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979468	HCTZ 12.5 MG / Losartan K+ 50 MG Oral Tablet	SY	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979470	HCTZ 12.5 MG / Losartan K+ 50 MG Oral Tablet [Hyzaar]	SY	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979464	HCTZ 12.5 MG / Losartan Pot 100 MG Oral Tablet	SY	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979466	HCTZ 12.5 MG / Losartan Pot 100 MG Oral Tablet [Hyzaar]	SY	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979468	HCTZ 12.5 MG / Losartan Pot 50 MG Oral Tablet	SY	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979470	HCTZ 12.5 MG / Losartan Pot 50 MG Oral Tablet [Hyzaar]	SY	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979464	HCTZ 12.5 MG / losartan potassium 100 MG Oral Tablet	SY	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979471	HCTZ 25 MG / Losartan K+ 100 MG Oral Tablet	SY	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979473	HCTZ 25 MG / Losartan K+ 100 MG Oral Tablet [Hyzaar]	SY	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979471	HCTZ 25 MG / Losartan Pot 100 MG Oral Tablet	SY	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979473	HCTZ 25 MG / Losartan Pot 100 MG Oral Tablet [Hyzaar]	SY	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979471	HCTZ 25 MG / losartan potassium 100 MG Oral Tablet	SY	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979466	Hyzaar 100/12.5 Oral Tablet	SY	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979473	Hyzaar 100/25 (hydrochlorothiazide 25 MG / losartan potassium 100 MG) Oral Tablet	SY	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979473	Hyzaar 100/25 Oral Tablet	SY	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979470	Hyzaar 50/12.5 (hydrochlorothiazide 12.5 MG / losartan potassium 50 MG) Oral Tablet	SY	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979470	Hyzaar 50/12.5 Oral Tablet	SY	d7d7dcc9-c3e0-45e5-abcd-135a6d8c8dab	3
979470	Hyzaar 50 MG / 12.5 MG Oral Tablet	PSN	b82d5bbc-2ead-4060-a37d-7cffb0d87423	1
979468	losartan potassium 50 MG / hydroCHLOROthiazide 12.5 MG Oral Tablet	PSN	b82d5bbc-2ead-4060-a37d-7cffb0d87423	1
979470	hydrochlorothiazide 12.5 MG / losartan potassium 50 MG Oral Tablet [Hyzaar]	SBD	b82d5bbc-2ead-4060-a37d-7cffb0d87423	1
979468	hydrochlorothiazide 12.5 MG / losartan potassium 50 MG Oral Tablet	SCD	b82d5bbc-2ead-4060-a37d-7cffb0d87423	1
979468	HCTZ 12.5 MG / Losartan K+ 50 MG Oral Tablet	SY	b82d5bbc-2ead-4060-a37d-7cffb0d87423	1
979470	HCTZ 12.5 MG / Losartan K+ 50 MG Oral Tablet [Hyzaar]	SY	b82d5bbc-2ead-4060-a37d-7cffb0d87423	1
979468	HCTZ 12.5 MG / Losartan Pot 50 MG Oral Tablet	SY	b82d5bbc-2ead-4060-a37d-7cffb0d87423	1
979470	HCTZ 12.5 MG / Losartan Pot 50 MG Oral Tablet [Hyzaar]	SY	b82d5bbc-2ead-4060-a37d-7cffb0d87423	1
979470	Hyzaar 50/12.5 (hydrochlorothiazide 12.5 MG / losartan potassium 50 MG) Oral Tablet	SY	b82d5bbc-2ead-4060-a37d-7cffb0d87423	1
979470	Hyzaar 50/12.5 Oral Tablet	SY	b82d5bbc-2ead-4060-a37d-7cffb0d87423	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
0006-0717-31	00006071731	30 TABLET, FILM COATED in 1 BOTTLE (0006-0717-31)	1995-04-28	0000-00-00	No	No	Current
0006-0717-54	00006071754	90 TABLET, FILM COATED in 1 BOTTLE (0006-0717-54)	1995-04-28	0000-00-00	No	No	Current
0006-0717-82	00006071782	1000 TABLET, FILM COATED in 1 BOTTLE (0006-0717-82)	1995-04-28	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
HYZAAR	Bryant Ranch Prepack	2021-12-22	HUMAN PRESCRIPTION DRUG LABEL	1004
HYZAAR	Merck Sharp & Dohme Corp.	2021-09-01	HUMAN PRESCRIPTION DRUG LABEL	33
HYZAAR	Aphena Pharma Solutions - Tennessee, LLC	2014-05-30	HUMAN PRESCRIPTION DRUG LABEL	1
HYZAAR	Physicians Total Care, Inc.	2012-11-02	HUMAN PRESCRIPTION DRUG LABEL	3